Skip to main contentSkip to navigation
Sirius Investors
HLK Biotech Holding Group, Inc.

HLK Biotech Holding Group, Inc.

AMHD
OTCHealthcare

HLK Biotech Holding Group, Inc. (AMHD) Investment Research Dashboard

About HLK Biotech Holding Group, Inc. (AMHD) stock analysis

Get live AMHD stock price $0.00, comprehensive HLK Biotech Holding Group, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time AMHD stock data and investment insights.

0.00
0.00%Today
Market Cap
925
Volume
100
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

HLK Biotech Holding Group, Inc. operates primarily through its various subsidiaries, focusing on the production and distribution of biodiesel. In addition to its energy sector activities, the company also engages in the acquisition of real estate ass...

Company Information

CEO
Anna Petinova
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5

Contact Information

Address
2612 Granby Street
Country
US

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for HLK Biotech Holding Group, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for HLK Biotech Holding Group, Inc.
  • Investors should consider how HLK Biotech Holding Group, Inc. fits within their overall portfolio allocation

Market Cap

925

Beta

0.96

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

75/100 ⭐⭐⭐⭐⭐

Overall
+0.5%
NYSE
+0.6%
NASDAQ
+0.5%
Sector1D1W1MP/EScore
Financial Services+1.8%+2.8%+3.9%19.3
98/100⭐⭐⭐⭐⭐
Healthcare+0.5%+1.2%+1.4%24.0
75/100⭐⭐⭐⭐⭐
Communication Services+1.4%-0.6%+3.0%22.2
74/100⭐⭐⭐⭐⭐
Basic Materials+0.6%+1.4%-0.1%25.2
66/100⭐⭐⭐⭐
Consumer Defensive+0.2%+2.2%+1.1%29.8
64/100⭐⭐⭐⭐
Real Estate+0.4%+0.9%-1.6%29.5
51/100⭐⭐⭐
Energy-1.8%-3.4%-3.8%19.2
39/100⭐⭐
Utilities-0.8%+0.2%-4.2%26.8
37/100⭐⭐
Consumer Cyclical+0.3%-1.7%-6.0%42.8
18/100
Industrials+0.2%-0.0%-10.3%30.0
15/100
Technology+0.3%-1.9%-7.4%40.6
13/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.